Global Targeted Radionuclide Drug Market Growth (Status and Outlook) 2026-2032
The global Targeted Radionuclide Drug market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Targeted Radionuclide Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Targeted Radionuclide Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Targeted Radionuclide Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Targeted Radionuclide Drug players cover POINT Biopharma, Telix, ITM AG, Bayer AG, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Targeted Radionuclide Drug Industry Forecast” looks at past sales and reviews total world Targeted Radionuclide Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Radionuclide Drug sales for 2026 through 2032. With Targeted Radionuclide Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Radionuclide Drug industry.
This Insight Report provides a comprehensive analysis of the global Targeted Radionuclide Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Radionuclide Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Radionuclide Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Radionuclide Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Radionuclide Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Radionuclide Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Targeted Radionuclide Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Targeted Radionuclide Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Targeted Radionuclide Drug is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Targeted Radionuclide Drug players cover POINT Biopharma, Telix, ITM AG, Bayer AG, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Targeted Radionuclide Drug Industry Forecast” looks at past sales and reviews total world Targeted Radionuclide Drug sales in 2025, providing a comprehensive analysis by region and market sector of projected Targeted Radionuclide Drug sales for 2026 through 2032. With Targeted Radionuclide Drug sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted Radionuclide Drug industry.
This Insight Report provides a comprehensive analysis of the global Targeted Radionuclide Drug landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Targeted Radionuclide Drug portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Targeted Radionuclide Drug market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted Radionuclide Drug and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted Radionuclide Drug.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted Radionuclide Drug market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Medicine
- Inhibitor
- Tumors
- Thyroid
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- POINT Biopharma
- Telix
- ITM AG
- Bayer AG
- Novartis
- Lantheus
- Curium Pharma
- Fusion Pharmaceuticals
- RadioMedix, Inc.
- Convergent Therapeutics
- IONETIX
- Clarity Pharmaceuticals
- RayzeBio, Inc
- AmbioPharm
- Bracco Imaging
- Navidea
- China Isotope & Radiation Corporation
- Yantai Dongcheng
- Grand Pharma
- Hengrui Medicine
- Yunnan Baiyao Group
- SmartNuclide Biopharma
- Sinotau
- Hexin Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Radionuclide Drug Market Size (2021-2032)
2.1.2 Targeted Radionuclide Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Targeted Radionuclide Drug by Country/Region (2021, 2025 & 2032)
2.2 Targeted Radionuclide Drug Segment by Type
2.2.1 Medicine
2.2.2 Inhibitor
2.2.3 Targeted Radionuclide Drug Market Size by Type
2.2.3.1 Targeted Radionuclide Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
2.3 Targeted Radionuclide Drug Segment by Application
2.3.1 Tumors
2.3.2 Thyroid
2.3.3 Others
2.3.4 Targeted Radionuclide Drug Market Size by Application
2.3.4.1 Targeted Radionuclide Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
3 TARGETED RADIONUCLIDE DRUG MARKET SIZE BY PLAYER
3.1 Targeted Radionuclide Drug Market Size Market Share by Player
3.1.1 Global Targeted Radionuclide Drug Revenue by Player (2021-2026)
3.1.2 Global Targeted Radionuclide Drug Revenue Market Share by Player (2021-2026)
3.2 Global Targeted Radionuclide Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED RADIONUCLIDE DRUG BY REGION
4.1 Targeted Radionuclide Drug Market Size by Region (2021-2026)
4.2 Global Targeted Radionuclide Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Radionuclide Drug Market Size Growth (2021-2026)
4.4 APAC Targeted Radionuclide Drug Market Size Growth (2021-2026)
4.5 Europe Targeted Radionuclide Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Targeted Radionuclide Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Targeted Radionuclide Drug Market Size by Country (2021-2026)
5.2 Americas Targeted Radionuclide Drug Market Size by Type (2021-2026)
5.3 Americas Targeted Radionuclide Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Radionuclide Drug Market Size by Region (2021-2026)
6.2 APAC Targeted Radionuclide Drug Market Size by Type (2021-2026)
6.3 APAC Targeted Radionuclide Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Radionuclide Drug Market Size by Country (2021-2026)
7.2 Europe Targeted Radionuclide Drug Market Size by Type (2021-2026)
7.3 Europe Targeted Radionuclide Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Radionuclide Drug by Region (2021-2026)
8.2 Middle East & Africa Targeted Radionuclide Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Targeted Radionuclide Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED RADIONUCLIDE DRUG MARKET FORECAST
10.1 Global Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.1.1 Global Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.1.2 Americas Targeted Radionuclide Drug Forecast
10.1.3 APAC Targeted Radionuclide Drug Forecast
10.1.4 Europe Targeted Radionuclide Drug Forecast
10.1.5 Middle East & Africa Targeted Radionuclide Drug Forecast
10.2 Americas Targeted Radionuclide Drug Forecast by Country (2027-2032)
10.2.1 United States Market Targeted Radionuclide Drug Forecast
10.2.2 Canada Market Targeted Radionuclide Drug Forecast
10.2.3 Mexico Market Targeted Radionuclide Drug Forecast
10.2.4 Brazil Market Targeted Radionuclide Drug Forecast
10.3 APAC Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.3.1 China Targeted Radionuclide Drug Market Forecast
10.3.2 Japan Market Targeted Radionuclide Drug Forecast
10.3.3 Korea Market Targeted Radionuclide Drug Forecast
10.3.4 Southeast Asia Market Targeted Radionuclide Drug Forecast
10.3.5 India Market Targeted Radionuclide Drug Forecast
10.3.6 Australia Market Targeted Radionuclide Drug Forecast
10.4 Europe Targeted Radionuclide Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Targeted Radionuclide Drug Forecast
10.4.2 France Market Targeted Radionuclide Drug Forecast
10.4.3 UK Market Targeted Radionuclide Drug Forecast
10.4.4 Italy Market Targeted Radionuclide Drug Forecast
10.4.5 Russia Market Targeted Radionuclide Drug Forecast
10.5 Middle East & Africa Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Targeted Radionuclide Drug Forecast
10.5.2 South Africa Market Targeted Radionuclide Drug Forecast
10.5.3 Israel Market Targeted Radionuclide Drug Forecast
10.5.4 Turkey Market Targeted Radionuclide Drug Forecast
10.6 Global Targeted Radionuclide Drug Forecast by Type (2027-2032)
10.7 Global Targeted Radionuclide Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Targeted Radionuclide Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 POINT Biopharma
11.1.1 POINT Biopharma Company Information
11.1.2 POINT Biopharma Targeted Radionuclide Drug Product Offered
11.1.3 POINT Biopharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 POINT Biopharma Main Business Overview
11.1.5 POINT Biopharma Latest Developments
11.2 Telix
11.2.1 Telix Company Information
11.2.2 Telix Targeted Radionuclide Drug Product Offered
11.2.3 Telix Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Telix Main Business Overview
11.2.5 Telix Latest Developments
11.3 ITM AG
11.3.1 ITM AG Company Information
11.3.2 ITM AG Targeted Radionuclide Drug Product Offered
11.3.3 ITM AG Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 ITM AG Main Business Overview
11.3.5 ITM AG Latest Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Information
11.4.2 Bayer AG Targeted Radionuclide Drug Product Offered
11.4.3 Bayer AG Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bayer AG Main Business Overview
11.4.5 Bayer AG Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Targeted Radionuclide Drug Product Offered
11.5.3 Novartis Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Targeted Radionuclide Drug Product Offered
11.6.3 Lantheus Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Lantheus Main Business Overview
11.6.5 Lantheus Latest Developments
11.7 Curium Pharma
11.7.1 Curium Pharma Company Information
11.7.2 Curium Pharma Targeted Radionuclide Drug Product Offered
11.7.3 Curium Pharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Curium Pharma Main Business Overview
11.7.5 Curium Pharma Latest Developments
11.8 Fusion Pharmaceuticals
11.8.1 Fusion Pharmaceuticals Company Information
11.8.2 Fusion Pharmaceuticals Targeted Radionuclide Drug Product Offered
11.8.3 Fusion Pharmaceuticals Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Fusion Pharmaceuticals Main Business Overview
11.8.5 Fusion Pharmaceuticals Latest Developments
11.9 RadioMedix, Inc.
11.9.1 RadioMedix, Inc. Company Information
11.9.2 RadioMedix, Inc. Targeted Radionuclide Drug Product Offered
11.9.3 RadioMedix, Inc. Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 RadioMedix, Inc. Main Business Overview
11.9.5 RadioMedix, Inc. Latest Developments
11.10 Convergent Therapeutics
11.10.1 Convergent Therapeutics Company Information
11.10.2 Convergent Therapeutics Targeted Radionuclide Drug Product Offered
11.10.3 Convergent Therapeutics Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Convergent Therapeutics Main Business Overview
11.10.5 Convergent Therapeutics Latest Developments
11.11 IONETIX
11.11.1 IONETIX Company Information
11.11.2 IONETIX Targeted Radionuclide Drug Product Offered
11.11.3 IONETIX Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 IONETIX Main Business Overview
11.11.5 IONETIX Latest Developments
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Information
11.12.2 Clarity Pharmaceuticals Targeted Radionuclide Drug Product Offered
11.12.3 Clarity Pharmaceuticals Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Clarity Pharmaceuticals Main Business Overview
11.12.5 Clarity Pharmaceuticals Latest Developments
11.13 RayzeBio, Inc
11.13.1 RayzeBio, Inc Company Information
11.13.2 RayzeBio, Inc Targeted Radionuclide Drug Product Offered
11.13.3 RayzeBio, Inc Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 RayzeBio, Inc Main Business Overview
11.13.5 RayzeBio, Inc Latest Developments
11.14 AmbioPharm
11.14.1 AmbioPharm Company Information
11.14.2 AmbioPharm Targeted Radionuclide Drug Product Offered
11.14.3 AmbioPharm Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 AmbioPharm Main Business Overview
11.14.5 AmbioPharm Latest Developments
11.15 Bracco Imaging
11.15.1 Bracco Imaging Company Information
11.15.2 Bracco Imaging Targeted Radionuclide Drug Product Offered
11.15.3 Bracco Imaging Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Bracco Imaging Main Business Overview
11.15.5 Bracco Imaging Latest Developments
11.16 Navidea
11.16.1 Navidea Company Information
11.16.2 Navidea Targeted Radionuclide Drug Product Offered
11.16.3 Navidea Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Navidea Main Business Overview
11.16.5 Navidea Latest Developments
11.17 China Isotope & Radiation Corporation
11.17.1 China Isotope & Radiation Corporation Company Information
11.17.2 China Isotope & Radiation Corporation Targeted Radionuclide Drug Product Offered
11.17.3 China Isotope & Radiation Corporation Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 China Isotope & Radiation Corporation Main Business Overview
11.17.5 China Isotope & Radiation Corporation Latest Developments
11.18 Yantai Dongcheng
11.18.1 Yantai Dongcheng Company Information
11.18.2 Yantai Dongcheng Targeted Radionuclide Drug Product Offered
11.18.3 Yantai Dongcheng Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Yantai Dongcheng Main Business Overview
11.18.5 Yantai Dongcheng Latest Developments
11.19 Grand Pharma
11.19.1 Grand Pharma Company Information
11.19.2 Grand Pharma Targeted Radionuclide Drug Product Offered
11.19.3 Grand Pharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Grand Pharma Main Business Overview
11.19.5 Grand Pharma Latest Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Information
11.20.2 Hengrui Medicine Targeted Radionuclide Drug Product Offered
11.20.3 Hengrui Medicine Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Hengrui Medicine Main Business Overview
11.20.5 Hengrui Medicine Latest Developments
11.21 Yunnan Baiyao Group
11.21.1 Yunnan Baiyao Group Company Information
11.21.2 Yunnan Baiyao Group Targeted Radionuclide Drug Product Offered
11.21.3 Yunnan Baiyao Group Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Yunnan Baiyao Group Main Business Overview
11.21.5 Yunnan Baiyao Group Latest Developments
11.22 SmartNuclide Biopharma
11.22.1 SmartNuclide Biopharma Company Information
11.22.2 SmartNuclide Biopharma Targeted Radionuclide Drug Product Offered
11.22.3 SmartNuclide Biopharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 SmartNuclide Biopharma Main Business Overview
11.22.5 SmartNuclide Biopharma Latest Developments
11.23 Sinotau
11.23.1 Sinotau Company Information
11.23.2 Sinotau Targeted Radionuclide Drug Product Offered
11.23.3 Sinotau Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Sinotau Main Business Overview
11.23.5 Sinotau Latest Developments
11.24 Hexin Pharmaceutical
11.24.1 Hexin Pharmaceutical Company Information
11.24.2 Hexin Pharmaceutical Targeted Radionuclide Drug Product Offered
11.24.3 Hexin Pharmaceutical Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Hexin Pharmaceutical Main Business Overview
11.24.5 Hexin Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Targeted Radionuclide Drug Market Size (2021-2032)
2.1.2 Targeted Radionuclide Drug Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Targeted Radionuclide Drug by Country/Region (2021, 2025 & 2032)
2.2 Targeted Radionuclide Drug Segment by Type
2.2.1 Medicine
2.2.2 Inhibitor
2.2.3 Targeted Radionuclide Drug Market Size by Type
2.2.3.1 Targeted Radionuclide Drug Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
2.3 Targeted Radionuclide Drug Segment by Application
2.3.1 Tumors
2.3.2 Thyroid
2.3.3 Others
2.3.4 Targeted Radionuclide Drug Market Size by Application
2.3.4.1 Targeted Radionuclide Drug Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
3 TARGETED RADIONUCLIDE DRUG MARKET SIZE BY PLAYER
3.1 Targeted Radionuclide Drug Market Size Market Share by Player
3.1.1 Global Targeted Radionuclide Drug Revenue by Player (2021-2026)
3.1.2 Global Targeted Radionuclide Drug Revenue Market Share by Player (2021-2026)
3.2 Global Targeted Radionuclide Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TARGETED RADIONUCLIDE DRUG BY REGION
4.1 Targeted Radionuclide Drug Market Size by Region (2021-2026)
4.2 Global Targeted Radionuclide Drug Annual Revenue by Country/Region (2021-2026)
4.3 Americas Targeted Radionuclide Drug Market Size Growth (2021-2026)
4.4 APAC Targeted Radionuclide Drug Market Size Growth (2021-2026)
4.5 Europe Targeted Radionuclide Drug Market Size Growth (2021-2026)
4.6 Middle East & Africa Targeted Radionuclide Drug Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Targeted Radionuclide Drug Market Size by Country (2021-2026)
5.2 Americas Targeted Radionuclide Drug Market Size by Type (2021-2026)
5.3 Americas Targeted Radionuclide Drug Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted Radionuclide Drug Market Size by Region (2021-2026)
6.2 APAC Targeted Radionuclide Drug Market Size by Type (2021-2026)
6.3 APAC Targeted Radionuclide Drug Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Targeted Radionuclide Drug Market Size by Country (2021-2026)
7.2 Europe Targeted Radionuclide Drug Market Size by Type (2021-2026)
7.3 Europe Targeted Radionuclide Drug Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Targeted Radionuclide Drug by Region (2021-2026)
8.2 Middle East & Africa Targeted Radionuclide Drug Market Size by Type (2021-2026)
8.3 Middle East & Africa Targeted Radionuclide Drug Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TARGETED RADIONUCLIDE DRUG MARKET FORECAST
10.1 Global Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.1.1 Global Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.1.2 Americas Targeted Radionuclide Drug Forecast
10.1.3 APAC Targeted Radionuclide Drug Forecast
10.1.4 Europe Targeted Radionuclide Drug Forecast
10.1.5 Middle East & Africa Targeted Radionuclide Drug Forecast
10.2 Americas Targeted Radionuclide Drug Forecast by Country (2027-2032)
10.2.1 United States Market Targeted Radionuclide Drug Forecast
10.2.2 Canada Market Targeted Radionuclide Drug Forecast
10.2.3 Mexico Market Targeted Radionuclide Drug Forecast
10.2.4 Brazil Market Targeted Radionuclide Drug Forecast
10.3 APAC Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.3.1 China Targeted Radionuclide Drug Market Forecast
10.3.2 Japan Market Targeted Radionuclide Drug Forecast
10.3.3 Korea Market Targeted Radionuclide Drug Forecast
10.3.4 Southeast Asia Market Targeted Radionuclide Drug Forecast
10.3.5 India Market Targeted Radionuclide Drug Forecast
10.3.6 Australia Market Targeted Radionuclide Drug Forecast
10.4 Europe Targeted Radionuclide Drug Forecast by Country (2027-2032)
10.4.1 Germany Market Targeted Radionuclide Drug Forecast
10.4.2 France Market Targeted Radionuclide Drug Forecast
10.4.3 UK Market Targeted Radionuclide Drug Forecast
10.4.4 Italy Market Targeted Radionuclide Drug Forecast
10.4.5 Russia Market Targeted Radionuclide Drug Forecast
10.5 Middle East & Africa Targeted Radionuclide Drug Forecast by Region (2027-2032)
10.5.1 Egypt Market Targeted Radionuclide Drug Forecast
10.5.2 South Africa Market Targeted Radionuclide Drug Forecast
10.5.3 Israel Market Targeted Radionuclide Drug Forecast
10.5.4 Turkey Market Targeted Radionuclide Drug Forecast
10.6 Global Targeted Radionuclide Drug Forecast by Type (2027-2032)
10.7 Global Targeted Radionuclide Drug Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Targeted Radionuclide Drug Forecast
11 KEY PLAYERS ANALYSIS
11.1 POINT Biopharma
11.1.1 POINT Biopharma Company Information
11.1.2 POINT Biopharma Targeted Radionuclide Drug Product Offered
11.1.3 POINT Biopharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 POINT Biopharma Main Business Overview
11.1.5 POINT Biopharma Latest Developments
11.2 Telix
11.2.1 Telix Company Information
11.2.2 Telix Targeted Radionuclide Drug Product Offered
11.2.3 Telix Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Telix Main Business Overview
11.2.5 Telix Latest Developments
11.3 ITM AG
11.3.1 ITM AG Company Information
11.3.2 ITM AG Targeted Radionuclide Drug Product Offered
11.3.3 ITM AG Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 ITM AG Main Business Overview
11.3.5 ITM AG Latest Developments
11.4 Bayer AG
11.4.1 Bayer AG Company Information
11.4.2 Bayer AG Targeted Radionuclide Drug Product Offered
11.4.3 Bayer AG Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Bayer AG Main Business Overview
11.4.5 Bayer AG Latest Developments
11.5 Novartis
11.5.1 Novartis Company Information
11.5.2 Novartis Targeted Radionuclide Drug Product Offered
11.5.3 Novartis Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Novartis Main Business Overview
11.5.5 Novartis Latest Developments
11.6 Lantheus
11.6.1 Lantheus Company Information
11.6.2 Lantheus Targeted Radionuclide Drug Product Offered
11.6.3 Lantheus Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Lantheus Main Business Overview
11.6.5 Lantheus Latest Developments
11.7 Curium Pharma
11.7.1 Curium Pharma Company Information
11.7.2 Curium Pharma Targeted Radionuclide Drug Product Offered
11.7.3 Curium Pharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Curium Pharma Main Business Overview
11.7.5 Curium Pharma Latest Developments
11.8 Fusion Pharmaceuticals
11.8.1 Fusion Pharmaceuticals Company Information
11.8.2 Fusion Pharmaceuticals Targeted Radionuclide Drug Product Offered
11.8.3 Fusion Pharmaceuticals Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Fusion Pharmaceuticals Main Business Overview
11.8.5 Fusion Pharmaceuticals Latest Developments
11.9 RadioMedix, Inc.
11.9.1 RadioMedix, Inc. Company Information
11.9.2 RadioMedix, Inc. Targeted Radionuclide Drug Product Offered
11.9.3 RadioMedix, Inc. Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 RadioMedix, Inc. Main Business Overview
11.9.5 RadioMedix, Inc. Latest Developments
11.10 Convergent Therapeutics
11.10.1 Convergent Therapeutics Company Information
11.10.2 Convergent Therapeutics Targeted Radionuclide Drug Product Offered
11.10.3 Convergent Therapeutics Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Convergent Therapeutics Main Business Overview
11.10.5 Convergent Therapeutics Latest Developments
11.11 IONETIX
11.11.1 IONETIX Company Information
11.11.2 IONETIX Targeted Radionuclide Drug Product Offered
11.11.3 IONETIX Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 IONETIX Main Business Overview
11.11.5 IONETIX Latest Developments
11.12 Clarity Pharmaceuticals
11.12.1 Clarity Pharmaceuticals Company Information
11.12.2 Clarity Pharmaceuticals Targeted Radionuclide Drug Product Offered
11.12.3 Clarity Pharmaceuticals Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Clarity Pharmaceuticals Main Business Overview
11.12.5 Clarity Pharmaceuticals Latest Developments
11.13 RayzeBio, Inc
11.13.1 RayzeBio, Inc Company Information
11.13.2 RayzeBio, Inc Targeted Radionuclide Drug Product Offered
11.13.3 RayzeBio, Inc Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 RayzeBio, Inc Main Business Overview
11.13.5 RayzeBio, Inc Latest Developments
11.14 AmbioPharm
11.14.1 AmbioPharm Company Information
11.14.2 AmbioPharm Targeted Radionuclide Drug Product Offered
11.14.3 AmbioPharm Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 AmbioPharm Main Business Overview
11.14.5 AmbioPharm Latest Developments
11.15 Bracco Imaging
11.15.1 Bracco Imaging Company Information
11.15.2 Bracco Imaging Targeted Radionuclide Drug Product Offered
11.15.3 Bracco Imaging Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Bracco Imaging Main Business Overview
11.15.5 Bracco Imaging Latest Developments
11.16 Navidea
11.16.1 Navidea Company Information
11.16.2 Navidea Targeted Radionuclide Drug Product Offered
11.16.3 Navidea Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Navidea Main Business Overview
11.16.5 Navidea Latest Developments
11.17 China Isotope & Radiation Corporation
11.17.1 China Isotope & Radiation Corporation Company Information
11.17.2 China Isotope & Radiation Corporation Targeted Radionuclide Drug Product Offered
11.17.3 China Isotope & Radiation Corporation Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 China Isotope & Radiation Corporation Main Business Overview
11.17.5 China Isotope & Radiation Corporation Latest Developments
11.18 Yantai Dongcheng
11.18.1 Yantai Dongcheng Company Information
11.18.2 Yantai Dongcheng Targeted Radionuclide Drug Product Offered
11.18.3 Yantai Dongcheng Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Yantai Dongcheng Main Business Overview
11.18.5 Yantai Dongcheng Latest Developments
11.19 Grand Pharma
11.19.1 Grand Pharma Company Information
11.19.2 Grand Pharma Targeted Radionuclide Drug Product Offered
11.19.3 Grand Pharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Grand Pharma Main Business Overview
11.19.5 Grand Pharma Latest Developments
11.20 Hengrui Medicine
11.20.1 Hengrui Medicine Company Information
11.20.2 Hengrui Medicine Targeted Radionuclide Drug Product Offered
11.20.3 Hengrui Medicine Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Hengrui Medicine Main Business Overview
11.20.5 Hengrui Medicine Latest Developments
11.21 Yunnan Baiyao Group
11.21.1 Yunnan Baiyao Group Company Information
11.21.2 Yunnan Baiyao Group Targeted Radionuclide Drug Product Offered
11.21.3 Yunnan Baiyao Group Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Yunnan Baiyao Group Main Business Overview
11.21.5 Yunnan Baiyao Group Latest Developments
11.22 SmartNuclide Biopharma
11.22.1 SmartNuclide Biopharma Company Information
11.22.2 SmartNuclide Biopharma Targeted Radionuclide Drug Product Offered
11.22.3 SmartNuclide Biopharma Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.22.4 SmartNuclide Biopharma Main Business Overview
11.22.5 SmartNuclide Biopharma Latest Developments
11.23 Sinotau
11.23.1 Sinotau Company Information
11.23.2 Sinotau Targeted Radionuclide Drug Product Offered
11.23.3 Sinotau Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.23.4 Sinotau Main Business Overview
11.23.5 Sinotau Latest Developments
11.24 Hexin Pharmaceutical
11.24.1 Hexin Pharmaceutical Company Information
11.24.2 Hexin Pharmaceutical Targeted Radionuclide Drug Product Offered
11.24.3 Hexin Pharmaceutical Targeted Radionuclide Drug Revenue, Gross Margin and Market Share (2021-2026)
11.24.4 Hexin Pharmaceutical Main Business Overview
11.24.5 Hexin Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Targeted Radionuclide Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Targeted Radionuclide Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Medicine
Table 4. Major Players of Inhibitor
Table 5. Targeted Radionuclide Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Table 8. Targeted Radionuclide Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Table 11. Global Targeted Radionuclide Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Targeted Radionuclide Drug Revenue Market Share by Player (2021-2026)
Table 13. Targeted Radionuclide Drug Key Players Head office and Products Offered
Table 14. Targeted Radionuclide Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Targeted Radionuclide Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Table 19. Global Targeted Radionuclide Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Targeted Radionuclide Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Targeted Radionuclide Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Targeted Radionuclide Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC Targeted Radionuclide Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Targeted Radionuclide Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Targeted Radionuclide Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Targeted Radionuclide Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Targeted Radionuclide Drug
Table 39. Key Market Challenges & Risks of Targeted Radionuclide Drug
Table 40. Key Industry Trends of Targeted Radionuclide Drug
Table 41. Global Targeted Radionuclide Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Targeted Radionuclide Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Targeted Radionuclide Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Targeted Radionuclide Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. POINT Biopharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 46. POINT Biopharma Targeted Radionuclide Drug Product Offered
Table 47. POINT Biopharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. POINT Biopharma Main Business
Table 49. POINT Biopharma Latest Developments
Table 50. Telix Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 51. Telix Targeted Radionuclide Drug Product Offered
Table 52. Telix Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Telix Main Business
Table 54. Telix Latest Developments
Table 55. ITM AG Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 56. ITM AG Targeted Radionuclide Drug Product Offered
Table 57. ITM AG Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. ITM AG Main Business
Table 59. ITM AG Latest Developments
Table 60. Bayer AG Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 61. Bayer AG Targeted Radionuclide Drug Product Offered
Table 62. Bayer AG Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Bayer AG Main Business
Table 64. Bayer AG Latest Developments
Table 65. Novartis Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 66. Novartis Targeted Radionuclide Drug Product Offered
Table 67. Novartis Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 70. Lantheus Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 71. Lantheus Targeted Radionuclide Drug Product Offered
Table 72. Lantheus Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Lantheus Main Business
Table 74. Lantheus Latest Developments
Table 75. Curium Pharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 76. Curium Pharma Targeted Radionuclide Drug Product Offered
Table 77. Curium Pharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Curium Pharma Main Business
Table 79. Curium Pharma Latest Developments
Table 80. Fusion Pharmaceuticals Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 81. Fusion Pharmaceuticals Targeted Radionuclide Drug Product Offered
Table 82. Fusion Pharmaceuticals Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Fusion Pharmaceuticals Main Business
Table 84. Fusion Pharmaceuticals Latest Developments
Table 85. RadioMedix, Inc. Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 86. RadioMedix, Inc. Targeted Radionuclide Drug Product Offered
Table 87. RadioMedix, Inc. Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. RadioMedix, Inc. Main Business
Table 89. RadioMedix, Inc. Latest Developments
Table 90. Convergent Therapeutics Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 91. Convergent Therapeutics Targeted Radionuclide Drug Product Offered
Table 92. Convergent Therapeutics Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Convergent Therapeutics Main Business
Table 94. Convergent Therapeutics Latest Developments
Table 95. IONETIX Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 96. IONETIX Targeted Radionuclide Drug Product Offered
Table 97. IONETIX Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. IONETIX Main Business
Table 99. IONETIX Latest Developments
Table 100. Clarity Pharmaceuticals Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 101. Clarity Pharmaceuticals Targeted Radionuclide Drug Product Offered
Table 102. Clarity Pharmaceuticals Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Clarity Pharmaceuticals Main Business
Table 104. Clarity Pharmaceuticals Latest Developments
Table 105. RayzeBio, Inc Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 106. RayzeBio, Inc Targeted Radionuclide Drug Product Offered
Table 107. RayzeBio, Inc Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. RayzeBio, Inc Main Business
Table 109. RayzeBio, Inc Latest Developments
Table 110. AmbioPharm Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 111. AmbioPharm Targeted Radionuclide Drug Product Offered
Table 112. AmbioPharm Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. AmbioPharm Main Business
Table 114. AmbioPharm Latest Developments
Table 115. Bracco Imaging Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 116. Bracco Imaging Targeted Radionuclide Drug Product Offered
Table 117. Bracco Imaging Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Bracco Imaging Main Business
Table 119. Bracco Imaging Latest Developments
Table 120. Navidea Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 121. Navidea Targeted Radionuclide Drug Product Offered
Table 122. Navidea Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Navidea Main Business
Table 124. Navidea Latest Developments
Table 125. China Isotope & Radiation Corporation Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 126. China Isotope & Radiation Corporation Targeted Radionuclide Drug Product Offered
Table 127. China Isotope & Radiation Corporation Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. China Isotope & Radiation Corporation Main Business
Table 129. China Isotope & Radiation Corporation Latest Developments
Table 130. Yantai Dongcheng Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 131. Yantai Dongcheng Targeted Radionuclide Drug Product Offered
Table 132. Yantai Dongcheng Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Yantai Dongcheng Main Business
Table 134. Yantai Dongcheng Latest Developments
Table 135. Grand Pharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 136. Grand Pharma Targeted Radionuclide Drug Product Offered
Table 137. Grand Pharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Grand Pharma Main Business
Table 139. Grand Pharma Latest Developments
Table 140. Hengrui Medicine Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 141. Hengrui Medicine Targeted Radionuclide Drug Product Offered
Table 142. Hengrui Medicine Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Hengrui Medicine Main Business
Table 144. Hengrui Medicine Latest Developments
Table 145. Yunnan Baiyao Group Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 146. Yunnan Baiyao Group Targeted Radionuclide Drug Product Offered
Table 147. Yunnan Baiyao Group Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Yunnan Baiyao Group Main Business
Table 149. Yunnan Baiyao Group Latest Developments
Table 150. SmartNuclide Biopharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 151. SmartNuclide Biopharma Targeted Radionuclide Drug Product Offered
Table 152. SmartNuclide Biopharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. SmartNuclide Biopharma Main Business
Table 154. SmartNuclide Biopharma Latest Developments
Table 155. Sinotau Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 156. Sinotau Targeted Radionuclide Drug Product Offered
Table 157. Sinotau Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Sinotau Main Business
Table 159. Sinotau Latest Developments
Table 160. Hexin Pharmaceutical Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 161. Hexin Pharmaceutical Targeted Radionuclide Drug Product Offered
Table 162. Hexin Pharmaceutical Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Hexin Pharmaceutical Main Business
Table 164. Hexin Pharmaceutical Latest Developments
Table 1. Targeted Radionuclide Drug Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Targeted Radionuclide Drug Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Medicine
Table 4. Major Players of Inhibitor
Table 5. Targeted Radionuclide Drug Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Table 8. Targeted Radionuclide Drug Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Table 11. Global Targeted Radionuclide Drug Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Targeted Radionuclide Drug Revenue Market Share by Player (2021-2026)
Table 13. Targeted Radionuclide Drug Key Players Head office and Products Offered
Table 14. Targeted Radionuclide Drug Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Targeted Radionuclide Drug Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Table 19. Global Targeted Radionuclide Drug Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Targeted Radionuclide Drug Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Targeted Radionuclide Drug Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Targeted Radionuclide Drug Market Size Market Share by Country (2021-2026)
Table 23. Americas Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Table 25. Americas Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Table 27. APAC Targeted Radionuclide Drug Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Table 29. APAC Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Targeted Radionuclide Drug Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Targeted Radionuclide Drug Market Size Market Share by Country (2021-2026)
Table 33. Europe Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Targeted Radionuclide Drug Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Targeted Radionuclide Drug Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Targeted Radionuclide Drug Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Targeted Radionuclide Drug
Table 39. Key Market Challenges & Risks of Targeted Radionuclide Drug
Table 40. Key Industry Trends of Targeted Radionuclide Drug
Table 41. Global Targeted Radionuclide Drug Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Targeted Radionuclide Drug Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Targeted Radionuclide Drug Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Targeted Radionuclide Drug Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. POINT Biopharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 46. POINT Biopharma Targeted Radionuclide Drug Product Offered
Table 47. POINT Biopharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. POINT Biopharma Main Business
Table 49. POINT Biopharma Latest Developments
Table 50. Telix Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 51. Telix Targeted Radionuclide Drug Product Offered
Table 52. Telix Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Telix Main Business
Table 54. Telix Latest Developments
Table 55. ITM AG Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 56. ITM AG Targeted Radionuclide Drug Product Offered
Table 57. ITM AG Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. ITM AG Main Business
Table 59. ITM AG Latest Developments
Table 60. Bayer AG Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 61. Bayer AG Targeted Radionuclide Drug Product Offered
Table 62. Bayer AG Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Bayer AG Main Business
Table 64. Bayer AG Latest Developments
Table 65. Novartis Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 66. Novartis Targeted Radionuclide Drug Product Offered
Table 67. Novartis Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Novartis Main Business
Table 69. Novartis Latest Developments
Table 70. Lantheus Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 71. Lantheus Targeted Radionuclide Drug Product Offered
Table 72. Lantheus Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Lantheus Main Business
Table 74. Lantheus Latest Developments
Table 75. Curium Pharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 76. Curium Pharma Targeted Radionuclide Drug Product Offered
Table 77. Curium Pharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Curium Pharma Main Business
Table 79. Curium Pharma Latest Developments
Table 80. Fusion Pharmaceuticals Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 81. Fusion Pharmaceuticals Targeted Radionuclide Drug Product Offered
Table 82. Fusion Pharmaceuticals Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. Fusion Pharmaceuticals Main Business
Table 84. Fusion Pharmaceuticals Latest Developments
Table 85. RadioMedix, Inc. Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 86. RadioMedix, Inc. Targeted Radionuclide Drug Product Offered
Table 87. RadioMedix, Inc. Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. RadioMedix, Inc. Main Business
Table 89. RadioMedix, Inc. Latest Developments
Table 90. Convergent Therapeutics Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 91. Convergent Therapeutics Targeted Radionuclide Drug Product Offered
Table 92. Convergent Therapeutics Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Convergent Therapeutics Main Business
Table 94. Convergent Therapeutics Latest Developments
Table 95. IONETIX Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 96. IONETIX Targeted Radionuclide Drug Product Offered
Table 97. IONETIX Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. IONETIX Main Business
Table 99. IONETIX Latest Developments
Table 100. Clarity Pharmaceuticals Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 101. Clarity Pharmaceuticals Targeted Radionuclide Drug Product Offered
Table 102. Clarity Pharmaceuticals Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. Clarity Pharmaceuticals Main Business
Table 104. Clarity Pharmaceuticals Latest Developments
Table 105. RayzeBio, Inc Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 106. RayzeBio, Inc Targeted Radionuclide Drug Product Offered
Table 107. RayzeBio, Inc Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. RayzeBio, Inc Main Business
Table 109. RayzeBio, Inc Latest Developments
Table 110. AmbioPharm Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 111. AmbioPharm Targeted Radionuclide Drug Product Offered
Table 112. AmbioPharm Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. AmbioPharm Main Business
Table 114. AmbioPharm Latest Developments
Table 115. Bracco Imaging Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 116. Bracco Imaging Targeted Radionuclide Drug Product Offered
Table 117. Bracco Imaging Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 118. Bracco Imaging Main Business
Table 119. Bracco Imaging Latest Developments
Table 120. Navidea Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 121. Navidea Targeted Radionuclide Drug Product Offered
Table 122. Navidea Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 123. Navidea Main Business
Table 124. Navidea Latest Developments
Table 125. China Isotope & Radiation Corporation Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 126. China Isotope & Radiation Corporation Targeted Radionuclide Drug Product Offered
Table 127. China Isotope & Radiation Corporation Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 128. China Isotope & Radiation Corporation Main Business
Table 129. China Isotope & Radiation Corporation Latest Developments
Table 130. Yantai Dongcheng Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 131. Yantai Dongcheng Targeted Radionuclide Drug Product Offered
Table 132. Yantai Dongcheng Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 133. Yantai Dongcheng Main Business
Table 134. Yantai Dongcheng Latest Developments
Table 135. Grand Pharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 136. Grand Pharma Targeted Radionuclide Drug Product Offered
Table 137. Grand Pharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 138. Grand Pharma Main Business
Table 139. Grand Pharma Latest Developments
Table 140. Hengrui Medicine Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 141. Hengrui Medicine Targeted Radionuclide Drug Product Offered
Table 142. Hengrui Medicine Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 143. Hengrui Medicine Main Business
Table 144. Hengrui Medicine Latest Developments
Table 145. Yunnan Baiyao Group Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 146. Yunnan Baiyao Group Targeted Radionuclide Drug Product Offered
Table 147. Yunnan Baiyao Group Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 148. Yunnan Baiyao Group Main Business
Table 149. Yunnan Baiyao Group Latest Developments
Table 150. SmartNuclide Biopharma Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 151. SmartNuclide Biopharma Targeted Radionuclide Drug Product Offered
Table 152. SmartNuclide Biopharma Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 153. SmartNuclide Biopharma Main Business
Table 154. SmartNuclide Biopharma Latest Developments
Table 155. Sinotau Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 156. Sinotau Targeted Radionuclide Drug Product Offered
Table 157. Sinotau Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 158. Sinotau Main Business
Table 159. Sinotau Latest Developments
Table 160. Hexin Pharmaceutical Details, Company Type, Targeted Radionuclide Drug Area Served and Its Competitors
Table 161. Hexin Pharmaceutical Targeted Radionuclide Drug Product Offered
Table 162. Hexin Pharmaceutical Targeted Radionuclide Drug Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 163. Hexin Pharmaceutical Main Business
Table 164. Hexin Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Targeted Radionuclide Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Radionuclide Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Targeted Radionuclide Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Targeted Radionuclide Drug Sales Market Share by Country/Region (2025)
Figure 8. Targeted Radionuclide Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Targeted Radionuclide Drug Market Size Market Share by Type in 2025
Figure 10. Targeted Radionuclide Drug in Tumors
Figure 11. Global Targeted Radionuclide Drug Market: Tumors (2021-2026) & ($ millions)
Figure 12. Targeted Radionuclide Drug in Thyroid
Figure 13. Global Targeted Radionuclide Drug Market: Thyroid (2021-2026) & ($ millions)
Figure 14. Targeted Radionuclide Drug in Others
Figure 15. Global Targeted Radionuclide Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Targeted Radionuclide Drug Market Size Market Share by Application in 2025
Figure 17. Global Targeted Radionuclide Drug Revenue Market Share by Player in 2025
Figure 18. Global Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Targeted Radionuclide Drug Value Market Share by Country in 2025
Figure 24. United States Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Targeted Radionuclide Drug Market Size Market Share by Region in 2025
Figure 29. APAC Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Targeted Radionuclide Drug Market Size Market Share by Country in 2025
Figure 38. Europe Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 61. China Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 65. India Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 68. France Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Targeted Radionuclide Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Targeted Radionuclide Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 1. Targeted Radionuclide Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Targeted Radionuclide Drug Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Targeted Radionuclide Drug Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Targeted Radionuclide Drug Sales Market Share by Country/Region (2025)
Figure 8. Targeted Radionuclide Drug Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Targeted Radionuclide Drug Market Size Market Share by Type in 2025
Figure 10. Targeted Radionuclide Drug in Tumors
Figure 11. Global Targeted Radionuclide Drug Market: Tumors (2021-2026) & ($ millions)
Figure 12. Targeted Radionuclide Drug in Thyroid
Figure 13. Global Targeted Radionuclide Drug Market: Thyroid (2021-2026) & ($ millions)
Figure 14. Targeted Radionuclide Drug in Others
Figure 15. Global Targeted Radionuclide Drug Market: Others (2021-2026) & ($ millions)
Figure 16. Global Targeted Radionuclide Drug Market Size Market Share by Application in 2025
Figure 17. Global Targeted Radionuclide Drug Revenue Market Share by Player in 2025
Figure 18. Global Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Figure 19. Americas Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 20. APAC Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 21. Europe Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Targeted Radionuclide Drug Market Size 2021-2026 ($ millions)
Figure 23. Americas Targeted Radionuclide Drug Value Market Share by Country in 2025
Figure 24. United States Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Targeted Radionuclide Drug Market Size Market Share by Region in 2025
Figure 29. APAC Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Figure 30. APAC Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Figure 31. China Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 35. India Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Targeted Radionuclide Drug Market Size Market Share by Country in 2025
Figure 38. Europe Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Figure 39. Europe Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Figure 40. Germany Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 41. France Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Targeted Radionuclide Drug Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Targeted Radionuclide Drug Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Targeted Radionuclide Drug Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Targeted Radionuclide Drug Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 54. APAC Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 55. Europe Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 57. United States Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 58. Canada Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 59. Mexico Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 60. Brazil Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 61. China Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 62. Japan Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 63. Korea Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 65. India Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 66. Australia Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 67. Germany Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 68. France Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 69. UK Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 70. Italy Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 71. Russia Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 72. Egypt Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 73. South Africa Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 74. Israel Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 75. Turkey Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
Figure 76. Global Targeted Radionuclide Drug Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Targeted Radionuclide Drug Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Targeted Radionuclide Drug Market Size 2027-2032 ($ millions)
